U.S. Neurosurgical Holdings, Inc.
USNU
$0.8854
$0.00180.20%
| Weiss Ratings | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.38 | |||
| Price History | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.62% | |||
| 30-Day Total Return | -5.56% | |||
| 60-Day Total Return | 0.76% | |||
| 90-Day Total Return | 26.49% | |||
| Year to Date Total Return | 10.68% | |||
| 1-Year Total Return | 36.19% | |||
| 2-Year Total Return | 785.40% | |||
| 3-Year Total Return | 342.70% | |||
| 5-Year Total Return | 342.70% | |||
| 52-Week High % Change | -54.45% | |||
| 52-Week Low % Change | 115.51% | |||
| Price | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.94 | |||
| 52-Week Low Price | $0.41 | |||
| 52-Week Low Price (Date) | May 31, 2024 | |||
| 52-Week High Price (Date) | Nov 15, 2024 | |||
| Valuation | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 17.92M | |||
| Enterprise Value | 14.82M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.09 | |||
| Earnings Per Share Growth | 298.16% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 4.20 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.89 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -9.60 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 17.01M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 301 208 8998 | |||
| Address | 2400 Research Boulevard Rockville, MD 20850 | |||
| Website | www.usneuro.com | |||
| Country | United States | |||
| Year Founded | 1993 | |||
| Profitability | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -41.26% | |||
| Return on Equity | -- | |||
| Income Statement | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -1.54M | |||
| Net Income (TTM) | -1.18M | |||
| Net Income Avl. to Common (TTM) | -1.18M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -93.33% | |||
| EPS Diluted (TTM) | -0.09 | |||
| EPS Diluted Growth (Q YOY) | -6.21% | |||
| Balance Sheet | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.17M | |||
| Cash Per Share (Q) | $0.19 | |||
| Total Current Assets (Q) | 3.19M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.66M | |||
| Current Ratio (Q) | 34.312 | |||
| Book Value Per Share (Q) | $0.21 | |||
| Total Assets (Q) | 3.80M | |||
| Total Current Liabilities (Q) | 93.00K | |||
| Total Debt (Q) | 67.00K | |||
| Total Liabilities (Q) | 143.00K | |||
| Total Common Equity (Q) | 3.66M | |||
| Cash Flow | USNU - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 227.00K | |||
| Cash from Financing (TTM) | 3.70M | |||
| Net Change in Cash (TTM) | 2.61M | |||
| Levered Free Cash Flow (TTM) | -1.07M | |||
| Cash from Operations (TTM) | -1.31M | |||
